Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Major capsid protein VP1 is the principal structural component of the JC polyomavirus (JCPyV) capsid, forming pentameric capsomeres that assemble into an icosahedral shell. It plays a critical role in viral pathogenesis by mediating attachment to host cells through specific interactions with alpha-2,6-linked sialic acid on lactotetrasaccharide series C (LSTc). In immunocompromised individuals, JCPyV can reactivate and cause progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease of the central nervous system. VP1 is a major target for therapeutic intervention, including neutralizing monoclonal antibodies (such as GRE1) and virus-like particle (VLP) vaccines designed to block viral entry or elicit protective humoral immunity. However, mutations in the outer loops of VP1 frequently arise in PML patients, allowing the virus to evade antibody-mediated neutralization and presenting a significant challenge for drug development.
Neutralizing antibodies and small molecules bind to the outer loops or receptor-binding pockets of VP1, preventing its interaction with host cell receptors (such as LSTc) and thereby blocking viral attachment and entry. Active immunization with VP1-based vaccines or virus-like particles (VLPs) stimulates the production of host neutralizing antibodies to prevent or control infection.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major capsid protein VP1 (VP1).